Table 2.
Compd | SKBR-3 cell growth inhibition (%) at 25μM | |
---|---|---|
17 | R2= H | 34.1 ± 2.9 |
18 | R2= CH3 | 38.5 ± 2.2 |
19 | R2= H | 53.6 ± 1.6 |
20 | R2= CH3 | 31.5 ± 4.9 |
21 | R2= H | 55.4 ± 2.4 |
22 | R2= CH3 | 41.7 ± 3.0 |
23 | R2= H | 65.7 ± 1.5 |
24 | R2= CH3 | 53.0 ± 2.9 |
25 | R2= H | 27.8 ± 2.6 |
26 | R2= CH3 | 37.6 ± 3.3 |
27 | R2= H | 26.4 ± 1.9 |
28 | R2= CH3 | 26.8 ± 3.7 |
29 | R2= H | 24.6 ± 3.2 |
30* | R2= CH3 | 81.6 ± 1.0 |
31 | R2= H | 41.8 ± 1.4 |
32 | R2= CH3 | 20.9 ± 5.0 |
33 | R2= H | 47.7 ± 3.1 |
34 | R2= CH3 | 7.0 ± 1.0 |
35 | R2= H | 42.7 ± 1.9 |
36 | R2= CH3 | 13.4 ± 2.2 |
37 | R2= H | 36.7 ± 1.2 |
38 | R2= CH3 | 38.6 ± 3.4 |
39 | R2= H | 28.6 ± 2.9 |
40 | R2= CH3 | 29.0 ± 4.6 |
41 | R2= H | 53.8 ± 2.1 |
42 | R2= CH3 | 61.4 ± 1.1 |
43 | R2= H | 63.7 ± 1.3 |
44* | R2= CH3 | 89.7 ± 0.4 |
SK-BR-3 cells were treated with indicated compounds at 25μM for 48 h and cell viability was measured by MTT assay as described in the experimental section, n = 6.
Significantly active compounds